Grid Therapeutics
NC - DurhamBiotechnology
Focus: Grid Therapeutics is an early-stage oncology biotech specializing in human-derived antibodies, based in Durham, NC. The company is pre-revenue with minimal pipeline maturity and a small team.
Profile data last refreshed 7h ago · AI intelligence enriched 1w ago
Open Jobs
8+1 this month
Stable — net +1 jobs in 30d
5 added, 4 removed. Backfill posture.
Should You Work at Grid Therapeutics?
AI assessmentGrid Therapeutics is a speculative early-stage bet suitable only for risk-tolerant scientists seeking equity upside and founding-team experience; financial opacity and minimal pipeline maturity present material career risk.
Why Work Here
- Founding-stage opportunity in antibody platform technology with potential for significant equity upside if pipeline validates
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Pembrolizumab
Non Small Cell Lung CancerOpen Jobs (8)
Help build intelligence for Grid Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.